APOBEC Reporter Systems for Evaluating diNucleotide Editing Levels
The CRISPR Journal · 2023
DOI: 10.1089/crispr.2023.0027 ↗Kurz gefasst
Fachartikel in der Zeitschrift The CRISPR Journal, 2023. Verfasst von Amanda E Rieffer und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, Molecular Biology, and Biophysics, University of Minnesota-Twin Cities, Minneapolis, Minnesota, USA; University of Texas …. Hauptthemen laut MEDLINE: Gene Editing, Epstein-Barr Virus Infections. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NCI NIH HHS.
Abstract (Originalsprache)
Precision genome editing has become a reality with the discovery of base editors. Cytosine base editor (CBE) technologies are improving rapidly but are mostly optimized for T C dinucleotide targets. Here, we report the development and implementation of APOBEC Reporter Systems for Evaluating diNucleotide Editing Levels (ARSENEL) in living cells. The ARSENEL panel is comprised of four constructs that quantitatively report editing of each of the four dinucleotide motifs (A C /C C /G C /T C ) through real-time accumulation of eGFP fluorescence. Editing rates of APOBEC3Bctd and AIDΔC CBEs reflect established mechanistic preferences with intrinsic biases to T C and G C , respectively. Twelve different (new and established) base editors are tested here using this system with a full-length APOBEC3B CBE showing the greatest on-target T C specificity and an APOBEC3A construct showing the highest editing efficiency. In addition, ARSENEL enables real-time assessment of natural and synthetic APOBEC inhibitors with the most potent to-date being the large subunit of the Epstein–Barr virus ribonucleotide reductase. These reporters have the potential to play important roles in research and development as precision genome engineering technologies progress toward achieving maximal specificity and efficiency.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry, Molecular Biology, and Biophysics, University of Minnesota-Twin Cities, Minneapolis, Minnesota, USA; University of Texas Health San Antonio, San Antonio, Texas, USA.
- Department of Biochemistry and Structural Biology, University of Texas Health San Antonio, San Antonio, Texas, USA; and University of Texas Health San Antonio, San Antonio, Texas, USA.
- Howard Hughes Medical Institute, University of Texas Health San Antonio, San Antonio, Texas, USA.
ORCID-Profile: Reuben S Harris
Förderung
- NIAID NIH HHS
- NCI NIH HHS
Zitieren
APA
Rieffer, A. E., Chen, Y., Salamango, D. J., Moraes, S. N., & Harris, R. S. (2023). APOBEC Reporter Systems for Evaluating diNucleotide Editing Levels. The CRISPR Journal. https://doi.org/10.1089/crispr.2023.0027
Vancouver
Rieffer AE, Chen Y, Salamango DJ, Moraes SN, Harris RS. APOBEC Reporter Systems for Evaluating diNucleotide Editing Levels. The CRISPR Journal. 2023. doi:10.1089/crispr.2023.0027
BibTeX
@article{Rieffer2023,
author = {Rieffer, Amanda E and Chen, Yanjun and Salamango, Daniel J and Moraes, Sofia N and Harris, Reuben S},
title = {APOBEC Reporter Systems for Evaluating diNucleotide Editing Levels},
journal = {The CRISPR Journal},
year = {2023},
doi = {10.1089/crispr.2023.0027}
}
EUVIMED